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Background: Many patients with Barrett’s esophagus do not adhere to guideline-recommended endoscopic
surveillance. Among patient factors related to cancer prevention behaviors, patients’ stated behavioral intention is a
strong predictor of behavior performance. Little is known about the patient factors associated with having a strong
behavioral intention to pursue surveillance endoscopy. This study explores the association of clinical and psychosocial
variables and behavioral intention to pursue surveillance endoscopy among patients with Barrett’s Esophagus and no
or low-grade dysplasia.
Methods: Potential subjects were screened using electronic medical records of a regional Veterans Affairs Medical
Center and a pathologically confirmed Barrett’s esophagus registry. Eligible participants were recruited by a mailer or
phone call and completed a questionnaire to measure six distinct psychosocial factors, their behavioral intention to
undergo surveillance endoscopy, and various demographic and clinical variables. Univariate and multivariate linear
regression identified the relation of behavioral intention with each of six psychosocial variables.
Results: One-hundred and one subjects consented and returned surveys. The analytical sample for this study consists
of the 94% of surveys with complete responses to the behavior intention items. Three of the six psychosocial domains
were statistically significant predictors of intention in both univariate and adjusted univariate analysis (salience/coherence
β = 0.59, 95% CI = 0.45-0.76, P <0.01; self-efficacy β = 0.30, 95% CI = 0.10-0.51, P <0.01; and social influence β = 0.20, 95%
CI = 0.08-0.33, P <0.01). In a multivariate analysis only salience/coherence (β = 0.65, 95% CI = 0.42-0.88, P <0.01)
remained statistically significant predictor of intention.
Conclusion: This study established the validity of a scale to measure psychosocial variables associated with behavioral
intentions to undergo surveillance endoscopy. Results demonstrate the importance of assessing self-efficacy, social
influences, and bottom-line belief in the value of surveillance endoscopy when evaluating a patient’s likelihood of
completing surveillance endoscopy.
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Detection of pre-cancerous lesions in breast, cervix, and
colorectal tissues has significantly decreased the occur-
rence of advanced stage cancers at diagnosis and their
associated mortality and morbidity in the United States
[1-3]. The prevalence of esophageal adenocarcinoma (EA)* Correspondence: Anaik@bcm.edu
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unless otherwise stated.is increasing in the United States and it carries an overall
5-year survival of 15-25% [4-6]. Barrett’s esophagus (BE), a
precancerous lesion of EA, occurs in the distal esophagus
and is characterized by the metaplasia of normal squa-
mous epithelium with intestinal epithelium. BE has the
potential to undergo dysplasia and evolve into EA [7]. The
annual rate of transformation to EA ranges from 0.5-1%
in non-dysplastic BE to 5-10% in those with high-grade
dysplasia [8-11].
Clinical practice guidelines recommend surveillance of
non-dysplastic BE via esophagoduodenoscopy (EGD) everyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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grade dysplasia [8,12,13]. The pattern of BE surveillance
in routine care is variable. In a cohort of over 29,000 pa-
tients with BE receiving care in a national integrated
healthcare system, less than 45% underwent BE surveil-
lance consistent with clinical practice guidelines [14].
Socio-demographic characteristics of patients and facility-
level factors did not explain surveillance patterns in this
study. Prior studies have highlighted the importance of in-
surance type and other financial incentives as drivers of
surveillance endoscopy [15,16]. Less is known about the
psychosocial promoters of BE surveillance behavior be-
yond perceptions of risk and anxiety [17].
The health promotion and disease prevention litera-
ture has established the most predictive determinant of
whether that individual performs a specific health behav-
ior is that individual’s behavioral intention (i.e., one’s
stated motivation to perform that specific action) [18].
The theory of reasoned action has further elaborated a
conceptual model of psychosocial variables that moder-
ate the relationship between one’s behavioral intention
and the likelihood of carrying out a particular health be-
havior [19]. Applications of this theory include studies of
colorectal cancer screening, condom use, adolescent sex-
ual behavior, smoking, prostate cancer screening, and
HIV treatment adherence [20-27]. For example, a pro-
spective study of colorectal cancer screening behavior
found that participants’ behavioral intentions, measured
by a self-reported questionnaire, was predictive of subse-
quent colorectal cancer screening initiation and mainten-
ance [28]. This measure of behavioral intention was
correlated with a number of psychosocial and behavioral
constructs including perceived susceptibility to colorectal















Figure 1 Conceptual model of factors associated with behavioral inte
illustrates the key domains that impact one’s intention to pursue esophage
characteristics and psychosocial domains influence the overall behavioral in
cancer endoscopic surveillance in this study.effectiveness of colonoscopy screening to detect colorectal
cancer (efficacy of testing), one’s “bottom-line” perception
about the value of colorectal cancer screening (salient/co-
herence), confidence in one’s ability to perform the behav-
ior assuming that one wanted to do so (self-efficacy), and
perception about what referent others (e.g., family friends,
respected experts, etc.) think and do with regard to per-
forming the behavior (social influence) [21,28].
Building from this evidence base, we propose a con-
ceptual model (see Figure 1) of how clinical, demo-
graphic and psychosocial variables relate to patients’
behavioral intention to undergo endoscopy for esopha-
geal cancer surveillance [29,30]. Furthermore, the vari-
ables in our model are consistent with survey variables
used in the prior study modeling behavioral intentions
for colorectal cancer screening [21,28-30]. The aim of
the current study is to explore the relationship between
these clinical and psychosocial variables and patients’ be-
havioral intention to undergo surveillance endoscopy.
Patients with pathologically confirmed BE received a
questionnaire eliciting their intention to undergo endos-
copy and responses to the psychosocial variables de-
scribed in our conceptual model (Figure 1).
Methods
Participants and data collection
Potential participants were identified and recruited in
two ways. First, we searched electronic medical records
(EMR) of a large regional Veterans Administration med-
ical center to identify patients scheduled for EGD for the
purpose of BE surveillance. Inclusion criteria for eligible
patients included those who were previously diagnosed
with BE with low-grade or no dysplasia by histology and















ntion to undergo endoscopic esophageal surveillance. This model
al cancer surveillance. Based on the theory of reasoned action, patient
tention to perform a health behavior which is undergoing esophageal
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study. We contacted patients who did not opt-out and
mailed study materials to willing respondents. This
method resulted in 68 participants (a 40% response rate
for those approached). The second method of recruit-
ment utilized a BE patient registry to identify eligible
participants. All of these participants also had a patho-
logically confirmed diagnosis of BE. Patients were mailed
a study information letter and survey. We received a
total of 66 surveys from two rounds of mail outs (a 34%
response rate for this portion of the sample).
We then conducted a secondary chart review to en-
sure all participants returning surveys met the BE sur-
veillance criteria. We define BE surveillance as an EGD
procedure occurring after a previous EGD resulting in a
pathologically confirmed BE diagnosis [29]. Exclusion
criteria for participants included the following: (1) under
18 or older than 80 years of age, (2) severe medical or
psychiatric co-morbidity, (3) were hospitalized at the
time of recruitment, (4) previous BE or gastroesophageal
disorders that would require endoscopy for reasons
other than BE screening or surveillance (i.e. gastroduo-
denal cancer, squamous cell esophageal cancer, gastric
ulcers, radiation, caustic ingestion, infectious esophagitis,
or HIV), (5) unable to undergo endoscopy (i.e. due to
gastric or esophageal surgery, resection, fundoplication,
or ulcer surgery), or (6) anemia, bleeding, cirrhosis, or
metastatic cancer. This secondary chart review resulted
in 33 participant surveys being excluded. A total of 101
participants met all inclusion criteria and were consented,
but seven had missing values for the intention measure
and were subsequently excluded. The remaining 94 partic-
ipants constitute the analytical sample of the current
study. This study was approved by the Institutional
Review Board for Baylor College of Medicine and the
Michael E. DeBakey Veteran Affairs (VA) Medical Center
research committee.
Instrument development
A validated instrument used to predict colorectal cancer
screening was modified for the development of this sur-
vey [21,31]. This instrument was modified to measure
patient’s intention to participate in an EGD for BE sur-
veillance and includes items measuring the variables de-
scribed in Figure 1. The scale includes 21 questions
forming 6 subscales or domains shown to predict behav-
ioral intention (one outcome). Respondents used a five-
point Likert scale to report their level of agreement with
each item, responses ranged from (1) not at all to (5)
extremely.
After modifying the scale we then field tested the in-
strument using cognitive interviewing to test the feasibil-
ity and face validity of the survey with a sample of
patients (n = 6) being seen in an outpatient GI clinic[32]. After completing the survey, a researcher went
through each response item-by-item probing for read-
ability and interpretation of each question. Items and
survey instructions were modified based on patient feed-
back. The participants enrolled in the current study re-
ceived this modified survey. Internal consistency of the
21-item modified study instrument to measure patient’s
intention to participate in an EGD for BE surveillance
was measured in our study sample using Cronbach’s
alpha. The study instrument had an overall Cronbach’s
alpha of 0.81 indicating good reliability in our study
sample.Dependent variable
Intention to complete an EGD was measured as the aver-
age between the two intention questions: “I intend to
undergo endoscopy” and “I do not intend to go through
endoscopy” (reverse-coded). Each item has a 5-point
Likert scale from strongly disagree (1) to strongly agree
(5). This intention measure is adapted from a validated
measure of colonoscopy intention that was found to be
highly predictive of receiving colonoscopy for initiation
of colorectal screening (odds ratio 2.34, 95% confidence
interval 1.44-3.81) and maintenance screening (odds ra-
tio 1.53, 95% confidence interval 1.03-2.63) in a multi-
variate, prospective study [28]. All study participants
included in our final analysis completed the intention to
complete EGD measure.Predictors of behavioral intention
Figure 1 illustrates our conceptual model describing the
predictors of behavioral intention to undergo surveil-
lance endoscopy. The survey items measuring each psy-
chosocial variable in Figure 1 were adapted from the
previously described survey of psychosocial predictors of
colorectal cancer screening and surveillance colonoscopy
among predominately male autoworkers [33]. Perceived
Susceptibility (3-items) measures the patient’s belief
about their chances of developing EA. Salience and
Coherence (4-items) is the patient’s belief that completing
the EGD is seen as important and makes sense to the
patient, i.e., the bottom-line importance of BE surveil-
lance. The patient’s belief in the efficacy of EGD and the
curability of EA was measured by 4-items. Self-efficacy
(3-items) represents the patient’s confidence in their
ability to complete the EGD or the steps necessary for
the EGD. A patient’s level of worry about the EGD and
the possibility of being diagnosed with EA were mea-
sured by 3-items. Social influence (2-items) measures a
patient’s familial influence and support to complete the
EGD (Additional file 1). Data is missing from three re-
spondents for the efficacy of EGD measure and from six
respondents for the social influence measure.
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Background variables were abstracted from patient elec-
tronic medical records as well as from survey items.
Background factors included demographic characteris-
tics (gender, age, marital status, income, education, and
race), degree of BE (non-dysplastic vs. dysplastic), Deyo
comorbidity score, and a literacy score. The Deyo co-
morbidity score is a modification of the Charlson co-
morbidity summary score. The score has been used to
predict mortality within one year of hospitalization. This
score is based on points assigned to fifteen specific ICD-
9 diagnostic and procedural codes recorded in a patient’s
EMR [34]. Health literacy was assessed by having partici-
pants respond to the question, “How confident are you
in filling out medical forms?” using a 5-point Likert scale
(scaled in ascending order of literacy). This single item
question has been validated to estimate functional health
literacy among English-speaking patient populations
with established, criterion measures of health literacy
[35]. Education data was missing for three respondents




Patient characteristics were reported using sample distri-
bution (Table 1). Mean/standard deviation was calculated
for continuous variables, and frequency for categoricalTable 1 Demographic and psychosocial characteristics of
Barrett’s esophagus patients (n = 94)
Demographics
Age in years, mean ± SD 63.3 ± 6.7
Gender male, n (%) 92 (97.9)
White race, n (%) 84 (89.4)
Some College or College Degree, n (%) 54 (59.3)
Married, n (%) 55 (58.5)
Functional health literacy*, mean ± SD 3.8 ± 1.2
Deyo comorbidity score, n (%)
Score = 0 48 (51.1)
Score = 1 21 (22.3)
Score >1 25 (26.6)
Predictors of behavioral intention* Mean ± SD
Perceived susceptibility 2.3 ± 1.1
Efficacy of EGD 3.4 ± 0.9
Worry 2.0 ± 0.9
Salience/Coherence 4.2 ± 0.8
Self-efficacy 3.9 ± 0.8
Social influence 2.9 ± 1.3
*All measured psychological domains and functional health literacy are scored
on a one to five point scale.
SD, standard deviation; EGD, esophagoduodenoscopy.variables. Age and literacy were continuous, whereas race
(white vs. others), education (some college or greater vs.
high school or less), and Deyo score (0, 1, or >1) were cat-
egorical variables.
Regression analysis
Univariate analysis was conducted using linear regres-
sion models to determine the predictor of participants’
reported intention to undergo EGD. Each behavioral and
psychosocial variable (perceived susceptibility, efficacy of
EGD, worry, salience/coherence, self-efficacy, and social
influences) was assessed in a separate univariate model.
We then adjusted each univariate model for patient
characteristics including age, race, education, functional
health literacy, and Deyo score. Lastly, multiple linear
regression was conducted including all behavioral and
psychosocial variables described under methods and ad-
justed for patient characteristics. All analyses were con-
ducted using SAS® 9.2.
Results
The total sample size for the study is 94 participants.
The group had a mean age of 63.4 years old and was
predominately male (97.8%). The sample was predomin-
ately white (89.4%) and college educated (59.3%). The
patients’ BE severity was noted as 81 (86%) with no dys-
plasia and 13 (14%) with low-grade dysplasia. Most indi-
viduals were married (58.5%). On average, participants
had moderate to good functional health literacy (score
3.8 along 5-point Likert scale). Comorbidity was gener-
ally low in this sample as almost three-quarters of all
participants had one or less comorbidity. Participants re-
ported a high overall mean score for intention to
undergo endoscopy with most scores falling from mod-
erate to very high (mean = 4.5 ± 0.8).
Summary of measured psychosocial variables
Distributions for behavioral and psychosocial variables
are described in the bottom portion of Table 1. Partici-
pants reported low to moderate scores (2.0-3.0) for
worry, perceived susceptibility, and social influence.
They also reported moderate scores (3.0-4.0) for per-
ceived efficacy of endoscopy and self-efficacy to comply
with endoscopy recommendations. Participants reported
highest scores for salience and coherence of the import-
ance of endoscopy.
Regression analyses
Univariate analysis indicated salience/coherence (β =
0.59, p < 0.01), self-efficacy (β = 0.39, p < 0.01), and social
influence (β = 0.17, p < 0.01) were predictors of behav-
ioral intention to undergo endoscopy in BE patients
(Table 2). Even after adjusting for patient characteris-
tics, salience/coherence (β = 0.60, p < 0.01), self-efficacy
Table 2 Predictors of behavioral intention to undergo endoscopy using univariate and adjusted linear regression models
Univariate models Adjusted, univariate models*
Predictors Parameter estimate 95% CI P-value Parameter estimate 95% CI P-value
Perceived susceptibility 0.01 −0.13 to 0.16 0.89 0.06 −0.08 to 0.20 0.37
Efficacy of EGD 0.12 −0.06 to 0.31 0.19 0.11 −0.07 to 0.29 0.23
Worry 0.02 −0.16 to 0.21 0.81 0.10 −0.09 to 0.28 0.29
Salience/Coherence 0.59 0.45 to 0.74 <0.01 0.60 0.45 to 0.76 <0.01
Self-efficacy 0.39 0.19 to 0.60 <0.01 0.30 0.10 to 0.51 <0.01
Social influence 0.17 0.05 to 0.30 <0.01 0.20 0.08 to 0.33 <0.01
*Adjusted for Race, Education, Age, Health Literacy, and categorical Deyo scores of 0, 1, and >1.
CI, confidence interval; EGD, esophagoduodenoscopy.
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remained significant predictors of intention (Table 2). Per-
ceived susceptibility to esophageal cancer, belief in the effi-
cacy of EGD surveillance, and worry about esophageal
cancer were not predictors of intention to undergo endos-
copy in either of these analyses.
Multiple regression analyses
Table 3 describes the results of a multivariate analysis
that models the association of participants reported
intention to undergo endoscopy with all psychosocial
variables adjusting for patient characteristics. This model
explains 57% of the overall variance in scores of partici-
pants’ intentions to undergo endoscopy. The only signifi-
cant predictor of intention to undergo endoscopy after
multivariate adjustment was salience/coherence (β = 0.65,Table 3 Multivariate linear regression analysis of





95% CI P value
Demographics
Age 0.01 −0.01 to 0.03 0.41
Race −0.34 −0.82 to 0.16 0.19
Education 0.05 −0.21 to 0.34 0.64
Health literacy 0.11 −0.19 to 0.46 0.07
Deyo score*
Score = 1 0.14 −0.19 to 0.46 0.41
Score >1 0.30 −0.03 to 0.62 0.07
Psychosocial variables
Perceived susceptibility −0.04 −0.20 to 0.12 0.63
Efficacy of EGD −0.03 −0.18 to 0.13 0.71
Worry 0.07 −0.12 to 0.25 0.48
Salience/Coherence 0.65 0.42 to 0.88 <0.01
Self-efficacy 0.02 −0.21 to 0.25 0.89
Social influence <−0.01 −0.13 to 0.13 0.95
*Deyo score of 0 is the referent group.
CI, confidence interval; EGD, esophagoduodenoscopy.p < 0.01). Self-efficacy and social influence were no longer
significant (p = 0.89 and p = 0.95, respectively).
Discussion
This study assessed the relationship of six psychosocial
variables elaborated in our conceptual model (see Figure 1)
to BE patients’ intention to pursue endoscopic surveil-
lance. Our analysis revealed three psychosocial variables
significantly associated with behavioral intention after
adjusting for patient characteristics: salience/coherence
(bottom-line importance of BE surveillance), self-efficacy
(patient’s confidence in their ability to complete the steps
necessary for surveillance), and social influence (patient’s
familial influence and support to complete endoscopic
surveillance). In a multivariate model that factored all six
psychosocial variables and adjusted for patient characteris-
tics, only salience/coherence remained significantly associ-
ated with intention to pursue BE surveillance. Worry and
perceived cancer risk, the psychosocial variables com-
monly attributed to cancer surveillance behaviors, were
not associated with behavioral intentions in this study.
Our study results build from and are consistent with
other studies evaluating patients’ intentions to pursue
gastrointestinal cancer screening and surveillance. The
survey items used in this study were adapted from a vali-
dated survey of psychosocial variables and behavioral in-
tentions to pursue colorectal cancer screening [20,31].
Our study measured similar psychosocial domains spe-
cifically related to behavioral intentions for surveillance
endoscopy in a sample of BE patients. The survey was
feasible to deliver by mail and in-person, had good in-
ternal consistency, and performed consistently with our
proposed conceptual model (Figure 1). This survey could
be used in future studies exploring patients’ psychosocial
and behavioral determinants of endoscopy for BE and
cancer surveillance.
Despite these strengths, the current study has limita-
tions. Our cross-sectional design and sampling strategy
limited our ability to evaluate a prospective relationship
between behavioral intention and receipt of endoscopic
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in disease prevention, broadly, and cancer screening, in
particular, delineating this predictive relationship [18].
Our study findings relied primarily on patient-reported
psychosocial variables, which may explain why partici-
pants’ responses to our behavioral intention measure
skewed towards the higher end of the Likert scale. Despite
this limitation, these survey measures were previously vali-
dated in a study of colorectal cancer screening and our
analytical model did include objective measures of clinical
and demographic characteristics.
The study population was composed primarily of pre-
dominately white, college-educated, male veterans re-
cruited from a population with a low response rate for
study enrollment. Selection bias might be present al-
though the demographics of those recruited were similar
to those of individuals diagnosed with BE in the VA na-
tional database. Despite this difficulty with recruitment,
the enrolled sample mirrors a larger sample of VA BE
patients with poor adherence to endoscopic surveillance
in regard to demographics including race and gender
(83.2% white and 97% male) [14]. The study results may
not be generalizable to the US general population in re-
gard to inherent patient characteristics including higher
level of education and health literacy. These same vari-
ables could impact the relationship of salience/coherence
and esophageal cancer endoscopic surveillance when
compared to a diverse sample. Additionally, this study
only measures psychosocial factors outlined in the the-
ory of reasoned action, but other unmeasured psycho-
social domains could influence behavioral intention in
this context. Lastly, the findings observed do provide
insight about psychosocial factors that predict esopha-
geal endoscopic surveillance in this sample, but the re-
sults may not be applicable to other cancer screening or
surveillance behaviors.
Future studies will need to expand and validate our sur-
vey instrument to confirm the relationships in our con-
ceptual model (Figure 1) and the predictive relation of
behavioral intention and receipt of surveillance endos-
copy. This study established the feasibility of measuring
important psychosocial domains that predict intention to
undergo BE surveillance. Conversely, we now need to bet-
ter understand the reasons why patients are non-adherent
to guideline-recommended endoscopic surveillance.
Conclusions
Finally, the results of the current study suggest that phy-
sicians should focus less on cancer-related worry and
risk when discussing BE surveillance and more on the
positive emotions related to confidence to complete en-
doscopy, bottom-line importance of BE surveillance, and
the encouragement of patients’ family members to
complete surveillance endoscopy.Additional file
Additional file 1: Items Comprising the Intention to Undergo
Esophageal Endoscopic Surveillance in Barrett’s Esophagus Survey,
stratified by domain.
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